Eight Hours of MSDH Approved Medical Cannabis CME !
Video Link's sent upon registration.
Questions: Jenny White ([email protected])

DISCLOSURE INFORMATION:

Faculty and planners for all MSMA Foundation sponsored CME activities are expected to disclose to the program audience whether they, or to the best of their knowledge, their affiliated institutions have received anything of value from commercial
sup- ports or any other commercial organizations that may constitute or be perceived as constituting a direct or indirect interest in the subject(s) of their presentation(s). Additionally, presenters are instructed to inform the audience if their presentations will
include a discussion of an unlabeled or investigational use of products or devices that have not yet been approved by the FDA for the use being discussed. The intent of disclosure is to make participants aware of each presenter’s interests or commitments so they may form their own judgments. To this end, disclosure information follows:

The following planning committee members for this educational activity have no relevant financial relationships to with ineligible companies to disclose:

            Ken Cleveland, MD                      Becky Wells

            Daniel Edney, MD                       Jenny White

The following committee members for this educational activity have no relevant financial relationships to with ineligible companies to disclose:

            Kris Jones Adcock, CPM, MSW     Thomas Dobbs, MD

            Claude Brunson, MD                    Daniel Edney, MD

            Ken Cleveland, MD                      Michelle Owens, MD       

            J. Anthony Cloy, MD                    Larry Walker, PhD

LEARNING OBJECTIVES

· Educate licensees on regulations involving medical cannabis prescribing.

· Educate licensees on how to become a Certifying Practitioner.

· Educate licensees on the differences between prescribing and certifying.

· Recognize the major components of Mississippi’s Medical Cannabis Program

· Identify the debilitating conditions that qualify patients to participate in the program

· Determine the practitioner application requirements to participate in the program

· Describe the practitioner certification required for patients to participate in the program

· Describe the current legal status of medical cannabis around the country and in MS

· Identify occupational considerations in the use of medical cannabis

· Discuss use of potentially impairing medications in the safety-sensitive worker

· Discuss the physiology of cannabis

· Become familiar with the available evidence surrounding cannabis use in vulnerable populations (specifically pregnancy-related use and in the adolescent population)

· Provide two known risks of cannabis use in these populations

· Overview the history of medical cannabis in the US

· Describe basic cannabis phytochemistry and the key relationships to products in legal and illicit markets

· Recognize elements of the endocannabinoid system and the pharmacological basis for positive or negative health impacts of THC

· Assess the pharmacology and pharmacokinetic behavior of THC when given by different routes of administration

· Understand how the products/limits allowable in the Mississippi Medical Cannabis Program compare to prescription cannabinoid dosing

· Discuss the components of the Mississippi Medical Cannabis Program

· Discuss the licensees application requirements to participate in the program

· Educate practitioners on the certification process required for patients to participate in the program

The Mississippi State Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Mississippi State Medical Association designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.